Compare Novartis AG (NVS) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Virgin Galactic Holdings, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Virgin Galactic Holdings, Inc. trades at $2.78 (market cap $329.06M). The key difference: Novartis AG is far larger — about 882.1× Virgin Galactic Holdings, Inc.'s market cap, and Novartis AG pays a 3.17% dividend while Virgin Galactic Holdings, Inc. pays none. Which is the better fit depends on your goals.
| NVS | SPCE | |
|---|---|---|
Market Cap | $290.25B | $329.06M |
Sector | Health | Industrials |
52-Week High | $168.62 | $7.52 |
52-Week Low | $113.50 | $2.17 |
Enterprise Value | $330.27B | $428.90M |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
